Back
Vanguard FTSE Canada All Cap ETF Vs. Dyne Therapeutics Industry Stock Comparison
Buy
79
VCN.TO
Vanguard FTSE Canada All Cap ETF
Last Price:
51.29
Seasonality Move:
3.4%
Buy
66
DYN
Dyne Therapeutics
Last Price:
30.40
Seasonality Move:
38.02%
Buy
79
Vanguard FTSE Canada All Cap ETF (VCN.TO)
is a Buy
Is Vanguard FTSE Canada All Cap ETF a Buy, Sell or Hold?
- The current Vanguard FTSE Canada All Cap ETF [VCN.TO] share price is $51.18. The Score for VCN.TO is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- VCN.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VCN.TO Stock Price Chart
What is Vanguard FTSE Canada All Cap ETF's stock price today?
-
The Vanguard FTSE Canada All Cap ETF share price today is $51.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCN.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $34.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
VCN.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 70.28 | Buy |
| Chaikin Money Flow: | 57369 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.66 - 50.64) | Buy |
| Bollinger Bands (100): | (45.69 - 49.57) | Buy |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.99 | Sell |
| Relative Strength Index (14 RSI): | 60.64 | Buy |
| Chaikin Money Flow: | 1192325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.99 - 33.51) | Buy |
| Bollinger Bands (100): | (31.49 - 42.59) | Sell |
VCN.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.51 | Buy |
| 20-day SMA: | 50.26 | Buy |
| 50-day SMA: | 49.23 | Buy |
| 200-day SMA: | 46.04 | Buy |
| 8-day EMA: | 50.64 | Buy |
| 20-day EMA: | 50.21 | Buy |
| 50-day EMA: | 49.29 | Buy |
| 200-day EMA: | 46.38 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.58 | Buy |
| 20-day SMA: | 30.81 | Buy |
| 50-day SMA: | 32.62 | Buy |
| 200-day SMA: | 32.06 | Buy |
| 8-day EMA: | 30.24 | Buy |
| 20-day EMA: | 30.74 | Buy |
| 50-day EMA: | 32.95 | Buy |
| 200-day EMA: | 30.83 | Buy |
Vanguard FTSE Canada All Cap ETF Earnings Growth & VCN.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.
Vanguard FTSE Canada All Cap ETF Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||